- Home
- DSX vs TLSA Comparison
DSX vs TLSA Comparison
Compare DSX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSX
- TLSA
- Stock Information
- Founded
- DSX 1999
- TLSA 2013
- Country
- DSX Greece
- TLSA United Kingdom
- Employees
- DSX N/A
- TLSA N/A
- Industry
- DSX Marine Transportation
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- DSX Consumer Discretionary
- TLSA Health Care
- Exchange
- DSX Nasdaq
- TLSA Nasdaq
- Market Cap
- DSX 172.5M
- TLSA 175.3M
- IPO Year
- DSX 2005
- TLSA 2000
- Fundamental
- Price
- DSX $1.61
- TLSA $1.46
- Analyst Decision
- DSX
- TLSA
- Analyst Count
- DSX 0
- TLSA 0
- Target Price
- DSX N/A
- TLSA N/A
- AVG Volume (30 Days)
- DSX 267.0K
- TLSA 256.3K
- Earning Date
- DSX 07-30-2025
- TLSA 06-17-2025
- Dividend Yield
- DSX 2.48%
- TLSA N/A
- EPS Growth
- DSX N/A
- TLSA N/A
- EPS
- DSX 0.05
- TLSA N/A
- Revenue
- DSX $225,498,000.00
- TLSA N/A
- Revenue This Year
- DSX N/A
- TLSA N/A
- Revenue Next Year
- DSX $12.09
- TLSA N/A
- P/E Ratio
- DSX $29.74
- TLSA N/A
- Revenue Growth
- DSX N/A
- TLSA N/A
- 52 Week Low
- DSX $1.27
- TLSA $0.63
- 52 Week High
- DSX $3.00
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- DSX 58.47
- TLSA 54.11
- Support Level
- DSX $1.38
- TLSA $1.30
- Resistance Level
- DSX $1.59
- TLSA $1.50
- Average True Range (ATR)
- DSX 0.07
- TLSA 0.11
- MACD
- DSX 0.01
- TLSA -0.01
- Stochastic Oscillator
- DSX 90.00
- TLSA 42.11
About DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.